Melrose J. The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline. Antioxidants 2023;12:663. [DOI: 10.3390/antiox12030663][Reference Citation Analysis]
2
André Vannier-santos M, Márcia Suarez-fontes A, Almeida-silva J, Lifsitch Viçosa A, Aurora Chavez Perez S, Marcel Hasslocher-moreno A, Parreiras Estolano da Silveira G, Fernandes Portela L, Magalhães Saraiva R. Translational Research on Chagas Disease: Focusing on Drug Combination and Repositioning. Chagas Disease - From Cellular and Molecular Aspects of Trypanosoma cruzi-Host Interactions to the Clinical Intervention 2022. [DOI: 10.5772/intechopen.104231][Reference Citation Analysis]
3
Fakhri S, Abdian S, Zarneshan SN, Moradi SZ, Farzaei MH, Abdollahi M. Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases. IJN 2022;Volume 17:299-331. [DOI: 10.2147/ijn.s347187][Cited by in Crossref: 1][Cited by in F6Publishing: 3][Article Influence: 1.0][Reference Citation Analysis]